Catastrophic payment for assisted reproduction techniques with conventional ovarian stimulation in the public health sector of South Africa: Frequency and coping strategies

Human Reproduction

Volumn 28, Issue 10, 2013, Pages 2755-2764

  Dyer, Silke J ^a   Sherwood, Kerry ^a   Mcintyre, Di ^b   Ataguba, John E ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Africa; assisted reproduction techniques; catastrophic payment; coping strategies; out of pocket payment

Indexed keywords

CLOMIFENE CITRATE; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; COPING BEHAVIOR; DRUG COST; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH INSURANCE; HOUSEHOLD; HUMAN; INFERTILITY; INFERTILITY THERAPY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OVARY HYPERSTIMULATION; PROSPECTIVE STUDY; PUBLIC HEALTH; PUBLIC HOSPITAL; QUESTIONNAIRE; REIMBURSEMENT; SOCIAL STATUS; SOUTH AFRICA; UNIVERSITY HOSPITAL; URBAN AREA;

AFRICA; ASSISTED REPRODUCTION TECHNIQUES; CATASTROPHIC PAYMENT; COPING STRATEGIES; OUT-OF-POCKET PAYMENT;

ADAPTATION, PSYCHOLOGICAL; ADULT; FEMALE; FINANCING, PERSONAL; HEALTH EXPENDITURES; HUMANS; OVULATION INDUCTION; PUBLIC HEALTH PRACTICE; PUBLIC SECTOR; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SOUTH AFRICA;

EID: 84885157353     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det290     Document Type: Article

References (49)

1. Ataguba JE. Reassessing catastrophic health care payments with a Nigerian case study. Health Econ Policy Law 2012;7:309-326.
2. Bosch E, Ezcurra D. Individualised controlled ovarian stimulation (iCOS): Maximising success rates for assisted reproductive technology patients. Reprod Biol Endocrinol 2011;9:82.
3. Collins JA. Cost-effectiveness of in vitro fertilization. Semin Reprod Med 2002; 19:279-289.
4. Connolly MP, Hoorens S, Chambers GM on behalf of ESHRE Reproduction and Society Task Force. The cost and consequences of assisted reproductive technology: An economic perspective. Hum Reprod Update 2010;16:603-613.
5. Daivadanam M, Thankappan K, Sarma P, Harikrishnan S. Catastrophic health expenditure & coping strategies associated with acute coronary syndrome in Kerala, India. Indian J Med Res 2012;136:585-592.
6. Dhont N, Luchters S, OmbeletW, Vyankandondera J, Gasarabwe A, van de Wijgert J, Temmerman M. Gender differences and factors associated with treatment-seeking behaviour for infertility in Rwanda. Hum Reprod 2010; 25:2024-2030.
7. Dhont N, van deWijgert J, Coene G, Gasarabwe A, Temmerman T. 'Mama and papa nothing': Living with infertility among an urban population in Kigali, Rwanda. Hum Reprod 2011;26:623-629.
8. Dyer SJ, Patel M. The economic impact of infertility on women in developing countries- A systematic review. FVV ObGyn 2012;4:102-109.
9. Dyer SJ, Abrahams N, Hoffman M, van der Spuy ZM. 'Men leave me as I cannot have children'-women's experiences with involuntary childlessness. Hum Reprod 2002;17:1663-1668.
10. Fauser BCJM, Nargund G, Anderson AN, Norman R, Tarlatzis B, Boivin J, Ledger W. Mild ovarian stimulation for IVF: 10 years later. Hum Reprod 2010;25:2678-2684.
11. Fledderjohann JJ. 'Zero is not good for me': Implications of infertility in Ghana. Hum Reprod 2012;27:383-1390.
12. Gerrits T. Social and cultural aspects of infertility in Mozambique. Patient Educ Couns 1997;31:39-48.
13. Hollos M, Larsen U. Motherhood in sub-Saharan Africa: The social consequences of infertility in an urban population in northern Tanzania. Cult Health Sex 2008;10:159-173.
14. Hollos M, Larsen U, Obono O, Whitehouse B. The problemof infertility in high fertility populations: Meanings, consequences and coping mechanisms in two Nigerian communities. Soc Sci Med 2009;68:2061-2068.
15. Inhorn MC. Global infertility and the globalization of new reproductive technologies: Illustrations from Egypt. Soc Sci Med 2003;56:1837-1851.
16. McIntyre D, Thiede M, Dahlgren G, Whitehead M. What are the economic consequences for households of illness and of paying for health care in lowand middle-income country contexts?. Soc Sci Med 2006;62:858-865.
17. Mogobe DK. Denying and preserving self: Batswana women's experiences of infertility. Afr J Reprod Health 2005;9:26-37.
18. Nachtigall RD. International disparities in access to infertility services. Fertil Steril 2006;85:871-875.
19. Nahar P. The link between infertility and poverty: Evidence from Bangladesh. Hum Fertil 2012;15:18-26.
20. Nahar P, Richters A. Suffering of childless women in Bangladesh: The intersection of social identities of gender and class. Anthropol Med 2011; 18:327-338.
21. Nargund G, Fauser BCJM, Macklon NS, OmbeletW, Nygren K, Frydman R, for the Rotterdam ISMAAR Consensus Group on Terminology for Ovarian Stimulation for IVF. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod 2007;22:2801-2804.
22. O'Donnell O, Van Doorslaer E, Wagstaff A, Lindelow M. Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation. Washington DC:World Bank Publications, 2008.
23. Ombelet W, Cooke I, Dyer S, Serour G, Devroey P. Infertility and the provision of infertility medical services in developing countries. Hum Reprod Update 2008;14:605-621.
24. Onwujekwe O, Hanson K, Uzochukwu B. Examining inequities in incidence of catastrophic health expenditures on different healthcare services and health facilities in Nigeria. PLOS ONE 2012;7:e40811.
25. Pennings G, DeWert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. Eshre Taskforce on Ethics and Law 14: Equity of access to assisted reproductive technology. Hum Reprod 2008;23:772-774.
26. Revellie A, Casano S, Salvagno F, Piane LD. Milder is better?. Advantages and disadvantages of 'mild' ovarian stimulation for human in vitro fertilsation. Reprod Biol Endocrinol 2011;9:25.
27. Russell S. Ability to pay for health care: Concepts and evidence. Health Policy Plan 1996;11:219-237.
28. Russell S. The economic burden of illness for households in developing countries: A review of studies focusing on malaria, tuberculosis and human immunodeficiency virus/acquired immunodeficiency syndrome. Am J Trop Med Hyg 2004;7s:147-155.
29. Shahine LK, Lamb LD, Lathi RB, Milki AA, Langen E, Westphal LM. Poor prognosis with in vitro fertilisation in Indian women compared to Caucasianwomen despite similarembryo quality. PLOSONE 2009;4:e7599.
30. Singh A, Dhaliwal LK, Kaur A. Infertility in a PHC in Northern India. J Fam Welfare 1996;42:51-56.
31. Siristatidis C, Trivella M, Chrelias C, Sioulas VD, Vrachnis N, Kassanos D. A short narrative review of the feasibility of adopting mild ovarian stimualtion for IVF as the current standard of care. Arch Gynecol Obstet 2012;286:505-510.
32. Smith JF, Eisenberg ML, Glidden D, Millstein SG, Cedars M, Walsh TJ, Showstack J, Pasch LA, Adler N, Katz PP. Socioeconomic disparities in the use and success of fertility treatments: Analysis of data from a prospective cohort in the United States. Fertil Steril 2011;96:95-101.
33. Smith-Spangler CM, Bhattacharya J, Goldhaber-Fiebert JD. Diabetes, its treatment, and catastrophic medical spending in 35 developing countries. Diabetes Care 2012;35:319-326.
34. StataCorp. Stata: Release 12 - Statistical software. College Station, TX: StataCorp LP, 2011.
35. Statistics South Africa. Population Census 2001 [On-line]. Available: Http://www. statssa.gov.za (January 2013, date last accessed).
36. Statistics South Africa. Income and expenditure of households 2005/2006: Data set. 2008. Pretoria: Statistics South Africa. Statistics South Africa. Quarterly Labour Force Survey: Quarter 3. Pretoria: Statistics South Africa, 2012.
37. Stewart LM, Holman CDJ, Hart R, Finn J, MaiQ, Preen DB. How effective is in vitro fertilization, and how can it be improved?. Fertil Steril 2011; 95:1677-1683.
38. Su TT, Kouyate B, Flessa S. Catastrophic household expenditure for health care in a low-income society: A study from Nouna District, Burkina Faso. BullWorld Health Organ 2006;84:21-27.
39. Sundby J. Infertility in the Gambia: Traditional and modern health care. Patient Educ Couns 1997;31:29-37.
40. Thuan NBT, Lofgren C, Chuc NKT, Janlert U, Lindholm L. Household out-of-pocket payments for illness: Evidence from Vietnam. BMC Pub Health 2006;6:283.
41. van Doorslaer E, O'Donnell O, Rannan-EliyaRP, Somanathan A, Adhikari SR, Garg CC, Harbianto D, Herrin AN, Huq MN, Ibragimova S. Catastrophic payments for health care in Asia. Health Econ 2007; 16:1159-1184.
42. Van Zandvoort H, de Koning K, Gerrits T. Viewpoint: Medical infertility care in low income countries: The case for concern in policy and practice. Trop Med Int Health 2001;6:563-569.
43. Vayena E, Peterson HB, Adamson D, Nygren KG. Assisted reproductive technologies in developing countries: Are we caring yet?. Fertil Steril 2009;92:413-416.
44. Verberg MFG, Macklon NS, Nargund G, Frydman R, Devroey P, Broekmans FJ, Fauser BCJM. Mild ovarian stimulation for IVF. Hum Reprod Update 2009;15:13-29.
45. Widge A. Seeking conception: Experiences of urban Indian women with in vitro fertilization. Patient Educ Couns 2005;59:226-233.
46. Wiersema NJ, Drukker AJ, Tien Dung MB, Hyunh Nu G, Than Nhu N, Lambalk CB. Consequences of infertility in developing countries: Results of a questionnaire and interview survey in the South of Vietnam. J Translat Med 2006;4:54-61.
47. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL. Household catastrophic health expenditure: A multicountry analysis. Lancet 2003; 362:111-117.
48. Xu K, Evans DB, Carrin G, Aguilar-Rivera AM, Musgrove P, Evans T. Protecting households from catastrophic health spending. Health Affairs 2007;26:972-983.
49. Zegers-Hochschild F, Adamson D, de Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, van der Poel S, on behalf of ICMART and WHO. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum Reprod 2009; 24:2683-2687.